Maraviroc
98%
- Product Code: 124963
CAS:
376348-65-1
| Molecular Weight: | 513.67 g./mol | Molecular Formula: | C₂₉H₄₁F₂N₅O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD13188530 | |
| Melting Point: | Boiling Point: | ||
| Density: | 1.29g/ml | Storage Condition: | -20℃ |
Product Description:
Maraviroc is primarily used in the treatment of HIV infection. It works by blocking the CCR5 receptor on the surface of immune cells, which prevents the HIV virus from entering and infecting these cells. This makes it particularly effective against CCR5-tropic HIV-1 strains. It is often prescribed as part of combination antiretroviral therapy (ART) to manage and control the progression of HIV, helping to reduce viral load and improve immune function. Maraviroc is typically used in patients who have already been treated with other HIV medications and have shown resistance or intolerance to them. It is also used in cases where the specific HIV strain is known to be CCR5-tropic, as determined by a tropism assay. The drug is administered orally and is generally well-tolerated, though it may have side effects such as dizziness, liver issues, or allergic reactions. Regular monitoring is required to ensure its effectiveness and safety during long-term use.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off-White Solid |
| Purity (%) | 97.5-100 |
| 1 H Nmr Spectrum | Consistent With Structure |
| Infrared Spectrum | Conforms To Structure |
| Lcms | Consistent With Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $60.96 |
+
-
|
| 0.025 | 10-20 days | $202.14 |
+
-
|
| 0.100 | 10-20 days | $503.37 |
+
-
|
Maraviroc
Maraviroc is primarily used in the treatment of HIV infection. It works by blocking the CCR5 receptor on the surface of immune cells, which prevents the HIV virus from entering and infecting these cells. This makes it particularly effective against CCR5-tropic HIV-1 strains. It is often prescribed as part of combination antiretroviral therapy (ART) to manage and control the progression of HIV, helping to reduce viral load and improve immune function. Maraviroc is typically used in patients who have already been treated with other HIV medications and have shown resistance or intolerance to them. It is also used in cases where the specific HIV strain is known to be CCR5-tropic, as determined by a tropism assay. The drug is administered orally and is generally well-tolerated, though it may have side effects such as dizziness, liver issues, or allergic reactions. Regular monitoring is required to ensure its effectiveness and safety during long-term use.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :